Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             22 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study) Shoji, Tadahiro
2017
80 2 p. 355-361
artikel
2 A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo Ueno, Makoto
2017
80 2 p. 307-315
artikel
3 Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes Miles, Dale R.
2017
80 2 p. 295-306
artikel
4 Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats Forsgård, Richard A.
2017
80 2 p. 317-332
artikel
5 Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells Xu, Li
2017
80 2 p. 235-242
artikel
6 Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience Mendivil, Alberto A.
2017
80 2 p. 405-410
artikel
7 Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity Liu, Chengcheng
2017
80 2 p. 287-293
artikel
8 Does “OPTINAB” strategy (“stop-and-go”) work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel–gemcitabine? Relias, Valerie
2017
80 2 p. 371-375
artikel
9 Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring Sabanathan, Dhanusha
2017
80 2 p. 385-393
artikel
10 Eribulin shows high concentration and long retention in xenograft tumor tissues Sugawara, Michiko
2017
80 2 p. 377-384
artikel
11 Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer Tsyganov, Matvey M.
2017
80 2 p. 251-260
artikel
12 Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation Ouyang, Wen-Chen
2017
80 2 p. 411-419
artikel
13 Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients Park, Wan-Su
2017
80 2 p. 363-369
artikel
14 Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients Burhenne, Jürgen
2017
80 2 p. 433-439
artikel
15 Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity Quintanilha, Júlia Coelho França
2017
80 2 p. 223-233
artikel
16 JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin Qiu, Mingning
2017
80 2 p. 275-286
artikel
17 Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma Ren, Kaiming
2017
80 2 p. 243-250
artikel
18 Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring Netterberg, Ida
2017
80 2 p. 343-353
artikel
19 Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy Boss, M. K.
2017
80 2 p. 421-431
artikel
20 Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer Takayoshi, Kotoe
2017
80 2 p. 333-342
artikel
21 TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies Burris, Howard A.
2017
80 2 p. 261-273
artikel
22 Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1) Yan, Xiaofei
2017
80 2 p. 395-403
artikel
                             22 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland